Pink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Generics Bulletin

Medtech Insight

Biological Product Suffix Submissions Limited To 10 Candidates By US FDA

Jan 16 2017

• By Sue Sutter

Related Content

Biologic Product Naming: US FDA Sticks With Suffixes ‘Devoid Of Meaning’

Jan 13 2017

Biologics Naming: WHO Final Plan, FDA Draft Guidance Incompatible

Feb 08 2016

WHO vs. FDA: How The Biologic Naming Plans Stack Up

Feb 08 2016

FDA Biosimilar Naming Policy Takes Middle-Of-The-Road Approach

Aug 27 2015

FDA's Biologics Naming Plan: Industry Wants 'Memorable' Suffixes

Nov 09 2015

WHO To Pilot ‘Biological Qualifier’ Scheme Despite Protests From Biosimilars Industry

Oct 28 2016

Amgen Exec Backs WHO’s ‘Biological Qualifier’, Says First Ones Could Be Issued By End Of 2017

Nov 16 2016

FDA's Biosimilar Suffix 'Error': Molehill Withdrawn But Mountain Coming?

Jun 27 2016

Additional Topics

United States Regulation Biosimilars Biologics BioPharmaceutical

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window